Trial · NCT06324214
Oral Supplementation During PR Participation in COPD
NCT06324214, Phase 2, Completed, McGill University Health Centre/Research Institute of the McGill University Health Centre
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Oral Supplementation During PR Participation in COPD. Trials, record NCT06324214. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06324214
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oral Supplementation During PR Participation in COPD
- NCT number
- NCT06324214
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 22 participants, actual
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Conditions
- Copd
- Interventions
- Urolithin A (Mitopure), Placebo
- First posted
- 2024-03-21
- Last updated
- 2026-10-15
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Primary Feasibility Outcome: Recruitment rate | From study launch to study completion at every visit until post-intervention visit (average week 14) | The proportion of participants who agree to participate out of the number of all potential participants asked to participate. Recruitment rate represents the primary feasibility outcome of the current pilot RCT. |
| Primary | Constant Work Rate Exercise Test (CWRET) | Pre-intervention (baseline) and Post-intervention (after 8 weeks) | Exercise test whereby the workload is constant and is calculated as a percentage of the peak power output observed in the incremental test. CWRET time represents the pre-specified primary outcome of the planned main RCT. |
| Secondary | Feasibility Outcome: Attrition rate | From study launch to study completion at every visit until post-intervention visit (average week 14) | The percentage of participants who do not complete the study out of all participants randomized. Outcome of the current pilot RCT. |
| Secondary | Adherence/Fidelity Outcome: Differences in dosed missed | 8 weeks | The total number of doses missed will be recorded and reported. Outcome of the current pilot RCT. |
| Secondary | Feasibility Outcome: Study test completion rate | From study launch to study completion at every visit until post-intervention visit (average week 14) | Study test completion rate of each assessment (percentage of participants who complete each assessment). Outcome of the current pilot RCT. |
| Secondary | Safety Outcome: Adverse events | 14 weeks | Adverse events (AEs) will be monitored from the signing of the Informed Consent Form (ICF) through completion of study participation. If any AEs do occur, study participants will be followed until symptoms have resolved or have returned to baseline levels. All outstanding AEs will be followed until resolution or until the participant's last study visit. |
| Secondary | 6-Minute Walk Test (6MWT) | Pre-intervention (baseline) and Post-intervention (after 8 weeks) | 6-Minute Walk Distance (6MWD) obtained on a standard 6MWT. |
| Secondary | Quadriceps strength | Pre-intervention (baseline) and Post-intervention (after 8 weeks) | 4-second maximum quadriceps strength test. |
| Secondary | Disease-specific impact on quality of life | Pre-intervention (baseline) and Post-intervention (after 8 weeks) | St. George's respiratory questionnaire (SGRQ) score is a patient reported outcome measuring quality of life from 0-100 where higher scores indicate worse quality of life. |
| Secondary | Burden of disease | Pre-intervention (baseline) and Post-intervention (after 8 weeks) | COPD assessment test (CAT) scores is a patient reported outcome measuring COPD symptom burden from 0-40 where higher scores indicate worse symptom burden. |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06324214
GET https://conductscience.org/api/trials/v1/NCT06324214/registered?page=2